Skip to content

Clinical trials

Brain Diseases trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Brain Diseases Country / region: Netherlands Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20121
20141
20151
20163
20172
20194
20201
20211
20232
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated6
Recruiting4
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Radboud University Medical Center4
UMC Utrecht3
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)2
TauRx Therapeutics Ltd2
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.2
AC Immune SA1
AstraZeneca1
BBB-Therapeutics B.V.1
Eli Lilly and Company1
Genentech, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Brain Diseases21
Nervous System Diseases11
Central Nervous System Diseases10
Neurodegenerative Diseases8
Alzheimer Disease6
Dementia6
Mental Disorders5
Delirium4
Neurocognitive Disorders4
Basal Ganglia Diseases3

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.